Treatment of the RCC cell lines also resulted in a reduced expression of the STAT3-regulated protein, cyclin D1 and increased processing of caspase-3 and PARP as compared to (DMSO) vehicle treated cells or curcumin (Figure 4D). The gene discussed is CASP3; the disease is renal cell carcinoma.